AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $3,899,512 | +16.3% | 48,995 | +2.1% | 0.31% | +5.9% |
| Q3 2023 | $3,354,371 | -2.7% | 47,995 | 0.0% | 0.29% | +2.1% |
| Q2 2023 | $3,448,921 | +17.7% | 47,995 | +1.1% | 0.28% | +11.0% |
| Q1 2023 | $2,929,492 | -20.0% | 47,495 | 0.0% | 0.26% | -23.2% |
| Q4 2022 | $3,663,289 | +55.4% | 47,495 | -10.1% | 0.33% | +1.8% |
| Q3 2022 | $2,358,000 | +16.5% | 52,845 | 0.0% | 0.33% | +24.4% |
| Q2 2022 | $2,024,000 | -10.8% | 52,845 | -3.6% | 0.26% | +8.7% |
| Q1 2022 | $2,270,000 | +43.6% | 54,845 | +31.1% | 0.24% | +52.5% |
| Q4 2021 | $1,581,000 | +14.6% | 41,845 | 0.0% | 0.16% | +3.3% |
| Q3 2021 | $1,379,000 | -17.7% | 41,845 | +68.4% | 0.15% | -16.4% |
| Q2 2021 | $1,676,000 | +19.1% | 24,845 | 0.0% | 0.18% | +9.6% |
| Q1 2021 | $1,407,000 | -31.9% | 24,845 | -2.0% | 0.17% | -35.8% |
| Q4 2020 | $2,065,000 | +16.7% | 25,345 | +2.0% | 0.26% | +7.4% |
| Q3 2020 | $1,770,000 | -13.4% | 24,845 | 0.0% | 0.24% | -19.3% |
| Q2 2020 | $2,044,000 | +39.8% | 24,845 | 0.0% | 0.30% | +17.2% |
| Q1 2020 | $1,462,000 | -59.9% | 24,845 | -29.5% | 0.26% | -49.7% |
| Q4 2019 | $3,643,000 | +505.1% | 35,241 | +18.5% | 0.51% | +459.3% |
| Q3 2019 | $602,000 | -20.1% | 29,741 | +1.7% | 0.09% | -18.0% |
| Q2 2019 | $753,000 | +81.0% | 29,241 | 0.0% | 0.11% | +79.0% |
| Q1 2019 | $416,000 | +407.3% | 29,241 | 0.0% | 0.06% | +342.9% |
| Q4 2018 | $82,000 | -21.9% | 29,241 | -4.3% | 0.01% | -6.7% |
| Q3 2018 | $105,000 | +28.0% | 30,551 | +19.6% | 0.02% | +15.4% |
| Q2 2018 | $82,000 | +70.8% | 25,551 | +30.7% | 0.01% | +62.5% |
| Q1 2018 | $48,000 | -56.0% | 19,551 | 0.0% | 0.01% | -52.9% |
| Q4 2017 | $109,000 | 0.0% | 19,551 | 0.0% | 0.02% | -5.6% |
| Q3 2017 | $109,000 | +0.9% | 19,551 | -0.5% | 0.02% | +5.9% |
| Q2 2017 | $108,000 | +40.3% | 19,651 | 0.0% | 0.02% | +30.8% |
| Q1 2017 | $77,000 | -42.1% | 19,651 | 0.0% | 0.01% | -45.8% |
| Q4 2016 | $133,000 | +11.8% | 19,651 | +29.7% | 0.02% | +9.1% |
| Q3 2016 | $119,000 | – | 15,151 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |